@article{CJCR1559,
author = {Xue-jun Guo and Pei-hua Ni and Li Li and Wei-wu Deng and Huan-ying Wan and Guo-chao Shi},
title = {DETECTION OF p53 GENE MUTATION OF BRONCHOSCOPIC SAMPLES IN THE PATIENTS SUSPECTED TO LUNG CANCER*},
journal = {Chinese Journal of Cancer Research},
volume = {12},
number = {4},
year = {2013},
keywords = {},
abstract = {Objective: To determine the feasibility of detecting p53 geue mutations for early diagnosis of lung cancer using the samples from bronchoscopic examination.
Methods: Point mutations of the exon 5 - 8 of p53 gene were detected in 85 bronchoscopic samples of 35 patients suspected to be lung cancer using silver staining PCR-SSCP.
Results: p53 gene mutations were founded in 10 of 35 patients(28.6%). The incidence of p53 gene mutations (14.9%) was obviously higher than the cytological positive incidence(2.9%) in samples of sputum, bronchoalveolar lavage and brush, especially for the sputum(27.7%). In the bronchoscopic biopsy specimens, the incidence of p53 gene mutations (12.5%) was lower than that of pathologic positive result (50.0%). However, in view of all the bronchoscopic samples, there was no statistically difference between cytopathologic positive results (11.8%) and the incidence of p53 gene mutations (14.1%). Although the p53 mutations were most common in the samples from the patients bronchoscopically manifested as neoplasm compared with other manifestations, there was no statistical difference. It is valuable to notice that 3 patients with p53 gene mutation merely presented as bronchial inflammation in bronchoscope.
Conclusion: Results indicated that the value of detecting p53 gene mutation for the diagnosis of lung cancer using the bronchoscopic samples was more superior to cytological examination and detection of p53 gene mutations in post-bronchoscopic sputum was easy and effective, may be used as a valuable method for early diagnosis of lung cancer.},
issn = {1993-0631}, url = {https://cjcr.amegroups.org/article/view/1559}
}